[go: up one dir, main page]

SE9001402L - Foerfarande foer framstaellning av kinazolinderivattives - Google Patents

Foerfarande foer framstaellning av kinazolinderivattives

Info

Publication number
SE9001402L
SE9001402L SE9001402A SE9001402A SE9001402L SE 9001402 L SE9001402 L SE 9001402L SE 9001402 A SE9001402 A SE 9001402A SE 9001402 A SE9001402 A SE 9001402A SE 9001402 L SE9001402 L SE 9001402L
Authority
SE
Sweden
Prior art keywords
general formula
lower alkyl
group
procedures
preparing
Prior art date
Application number
SE9001402A
Other languages
English (en)
Swedish (sv)
Other versions
SE9001402D0 (sv
Inventor
J Reiter
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU193089A external-priority patent/HU203333B/hu
Priority claimed from HU193189A external-priority patent/HU203342B/hu
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of SE9001402D0 publication Critical patent/SE9001402D0/xx
Publication of SE9001402L publication Critical patent/SE9001402L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE9001402A 1989-04-21 1990-04-20 Foerfarande foer framstaellning av kinazolinderivattives SE9001402L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU193089A HU203333B (en) 1989-04-21 1989-04-21 Process for producing n-cyano-carboxamidine derivatives
HU193189A HU203342B (en) 1989-04-21 1989-04-21 Process for producing quinazoline deivatives

Publications (2)

Publication Number Publication Date
SE9001402D0 SE9001402D0 (sv) 1990-04-20
SE9001402L true SE9001402L (sv) 1990-10-22

Family

ID=26317437

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9001402A SE9001402L (sv) 1989-04-21 1990-04-20 Foerfarande foer framstaellning av kinazolinderivattives

Country Status (16)

Country Link
JP (1) JPH02292282A (de)
KR (1) KR900016194A (de)
AT (1) AT398075B (de)
BG (1) BG91821A (de)
CA (2) CA2015066A1 (de)
CH (1) CH681300A5 (de)
DK (1) DK99090A (de)
ES (1) ES2019826A6 (de)
FI (1) FI902002A0 (de)
GB (1) GB2231571B (de)
GR (1) GR900100294A (de)
IT (1) IT1241128B (de)
PL (1) PL162976B1 (de)
RU (1) RU1838309C (de)
SE (1) SE9001402L (de)
YU (1) YU70890A (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2077252C (en) * 1992-08-31 2001-04-10 Khashayar Karimian Methods of making ureas and guanidines, and intermediates therefor
ES2096518B1 (es) * 1994-03-28 1997-12-01 Grupo Farmaceutico Almirall S Nuevas anilinas.
WO2008015525A2 (en) * 2006-07-31 2008-02-07 Orchid Chemicals & Pharmaceuticals Limited An improved process for the preparation of alfuzosin hydrochloride
US20100174073A1 (en) 2007-05-04 2010-07-08 Actavis Group Ptc Ehf Process for the preparation of alfuzosin and salts thereof
CA2695076A1 (en) 2007-08-02 2009-02-05 Rajendra Narayanrao Kankan Process for the preparation of alfuzosin hydrochloride

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4026894A (en) * 1975-10-14 1977-05-31 Abbott Laboratories Antihypertensive agents
US4044135A (en) * 1975-10-14 1977-08-23 Abbott Laboratories Antihypertensive agents
GB1591490A (en) * 1977-08-04 1981-06-24 Abbott Lab 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate
US4138561A (en) * 1977-09-30 1979-02-06 Bristol-Myers Company Cyanocarboxamidines and quinazoline process
FI57751C (fi) * 1977-10-25 1980-10-10 Fermion Oy Foerfarande foer framstaellning av 6,7-dimetoxi- eller 6,7,8-trimetoxi-4-amino-2-(4-substituerade-piperazin-1-yl)-kinazoliner med blodtryckssaenkande verkan
FI56836C (fi) * 1977-10-25 1980-04-10 Fermion Oy 4-substituerade piperazin-1-(n-aryl-n'-cyano)-karboximidamider som aer mellanprodukter vid framstaellningen av farmakologiskt vaerdefulla 6,7-dimetoxi- eller 6,7,8-trimetoxi-4-amino-2-(4-substituerade-piperazin-1-yl)-kinazoliner
FR2421888A1 (fr) * 1978-02-06 1979-11-02 Synthelabo Amides d'alkylene-diamines et leur application en therapeutique
FI59800C (fi) * 1979-01-10 1981-10-12 Fermion Oy Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(furo-2-yl)-piperazin-1-yl)-kinazolin
FI67699C (fi) * 1979-01-31 1985-05-10 Orion Yhtymae Oy Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan
ATE32074T1 (de) * 1983-11-22 1988-02-15 Heumann Ludwig & Co Gmbh Verfahren zur herstellung von 4-amino-6,7dimethoxy-2-(4-(furo-2-yl)-piperazin-1-yl)chinazolin und dessen physiologisch annehmbarer salze.

Also Published As

Publication number Publication date
RU1838309C (ru) 1993-08-30
GB2231571B (en) 1992-09-16
PL284860A1 (en) 1991-03-11
ATA93190A (de) 1994-01-15
GR900100294A (el) 1991-09-27
CH681300A5 (de) 1993-02-26
SE9001402D0 (sv) 1990-04-20
FI902002A0 (fi) 1990-04-20
PL162976B1 (pl) 1994-01-31
CA2028953A1 (en) 1990-10-22
AT398075B (de) 1994-09-26
CA2015066A1 (en) 1990-10-21
YU70890A (en) 1992-05-28
BG91821A (bg) 1993-12-24
IT9020092A1 (it) 1991-10-20
DK99090D0 (da) 1990-04-20
DK99090A (da) 1990-10-22
IT9020092A0 (it) 1990-04-20
GB2231571A (en) 1990-11-21
KR900016194A (ko) 1990-11-12
GB9008941D0 (en) 1990-06-20
JPH02292282A (ja) 1990-12-03
ES2019826A6 (es) 1991-07-01
IT1241128B (it) 1993-12-29

Similar Documents

Publication Publication Date Title
ATE89559T1 (de) Camptothecin-derivate und verfahren zu ihrer herstellung.
ES8506677A1 (es) Un procedimiento para la preparacion de nuevos derivados de 8-cloro71,5-benzotiazepina.
CA2053253A1 (en) New aryl-and heteroarylethenylene derivatives and process for their preparation
NO914786L (no) Forbedret fremgangsmaate for fremstilling av substituerte isoflavonderivater
HUT43570A (en) Process for preparing novel decahydroquinoline derivatives and their salts, as well as pharmaceutics comprising the derivatives
SE7501365L (de)
KR890011904A (ko) 안드로스타-1,4, -디엔-3,17-디온의 6-메틸렌 유도체 합성방법
IE852285L (en) Piperazinylindanes
SE9001402L (sv) Foerfarande foer framstaellning av kinazolinderivattives
RU94033098A (ru) Способ производных 1-замещенного-5/4h/-тетразолинона
DK682288D0 (da) Fremgangsmaade til fremstilling af quinolincarboxylsyrer
ES8609212A1 (es) Un procedimiento para la preparacion de derivados de etanolamina.
ES458957A1 (es) Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3-aminopropanos.
YU46433B (sh) Postupak za dobijanje kondenzovanih derivata pirimidina
HUT47938A (en) Process for producing indoloquinoxaline derivatives with substituent in 6-position containing cyclic group, as well as pharmaceuticals comprising these compounds as active ingredient
HU900728D0 (en) Process for preparation of calcium antagonistics
KR960007534A (ko) 신규한 아민 유도체, 그의 제조방법 및 항부정맥제로서의 용도
ES432790A1 (es) Un metodo para producir derivados del acido 2-cloropropioni-co.
ES407856A1 (es) Procedimiento para preparar imidazolinas tetrasustituidas.
JPS5555160A (en) Preparation of substituted benzamide
DE60124831D1 (de) Ein verfahren zur herstellung substituierter alkylamin-derivate
DE68926016D1 (de) Halogeno-4-Methylpyrazole und Verfahren zu ihrer Herstellung
ES8200661A1 (es) Un procedimiento para la preparacion de nuevos derivados de dihidropiridina
ES2021483A6 (es) Procedimiento para preparar derivados de quinazolinona.
MY104048A (en) New allylaminoethylazoles.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9001402-8

Format of ref document f/p: F